Back to top
more

McKesson (MCK)

(Delayed Data from NYSE)

$525.28 USD

525.28
842,078

-0.66 (-0.13%)

Updated Nov 5, 2024 04:00 PM ET

After-Market: $525.55 +0.27 (0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 250)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

LabCorp's (LH) Covance Arm Stays Robust Amid Procedure Delay

by Zacks Equity Research

Apart from COVID-19 supports, LabCorp (LH) is making significant strides in other businesses.

Integra (IART) Sells Unprofitable Arm to Focus on Core Business

by Zacks Equity Research

Integra (IART) does not expect the selloff to have a material impact on its 2020 results.

Here's Why You Should Retain Integer Holdings (ITGR) Stock Now

by Zacks Equity Research

Integer Holdings (ITGR) continues to gain traction from portfolio management. However, intense competition is a woe.

OPKO Health's (OPK) BioReference Starts Fan Testing Program

by Zacks Equity Research

OPKO Health's (OPK) BioReference commences mandatory, large-scale COVID-19 testing programs for fans for AFC Division Wild Card playoff game.

Here's Why You Should Add DaVita (DVA) to Your Portfolio Now

by Zacks Equity Research

Investor confidence is high on DaVita (DVA) stock, driven by its solid prospects.

Should Value Investors Buy McKesson (MCK) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Here's Why You Should Hold on to Cerner (CERN) Stock Now

by Zacks Equity Research

Cerner (CERN) continues to gain from solid prospects in EHR and strategic deals. However, intense competition remains a woe.

    MCK or CNMD: Which Is the Better Value Stock Right Now?

    by Zacks Equity Research

    MCK vs. CNMD: Which Stock Is the Better Value Option?

    Here's Why You Must Add Accuray (ARAY) to Your Portfolio Now

    by Zacks Equity Research

    Investor confidence is high on Accuray (ARAY) stock, courtesy of its solid prospects.

    Sandip Chakraborty headshot

    5 Stocks That Could Hit Several New Highs in 2021

    by Sandip Chakraborty

    Given the upbeat sentiments in the market, FedEx (FDX), Deere (DE), D.R. Horton (DHI), Fortescue (FSUGY) and Fiat Chrysler (FCAU) are expected to give good returns to investors in 2021.

    Here's Why You Should Hold on to Intuitive Surgical (ISRG) Now

    by Zacks Equity Research

    Intuitive Surgical (ISRG) continues to gain traction from improving adoption of da Vinci Surgical System. But weak operational performance is a woe.

    Nevro's (NVRO) FDA Submission to Treat Patients With PDN

    by Zacks Equity Research

    Nevro's (NVRO) submission of a pre-market approval supplement to the FDA to seek approval for its Senza System can help in the treatment of chronic pain associated with PDN.

    Why You Must Add Merit Medical (MMSI) Stock to Your Portfolio

    by Zacks Equity Research

    Investor optimism is high on Merit Medical (MMSI) stock, courtesy of solid prospects.

    HMS Holdings (HMSY) to be Acquired by Gainwell for $3.4B

    by Zacks Equity Research

    HMS Holdings (HMSY) entered into an agreement to be acquired by Gainwell in an all-cash transaction deal worth about $3.4 billion.

    Here's Why You Should Retain Cooper Companies (COO) Stock

    by Zacks Equity Research

    Cooper Companies (COO) continues to benefit from solid CVI and CSI product portfolios.

    Intersect ENT (XENT) Banks on SINUVA Sales Amid COVID-19 Woes

    by Zacks Equity Research

    Intersect ENT's (XENT) potential in chronic sinusitis market and progress in SINUVA and PROPEL product lines are encouraging.

    Urmimala Biswas headshot

    5 Finest GARP Stocks Based on Discounted PEG

    by Urmimala Biswas

    Here we discuss five GARP stocks, TAP, OMI, TD, MCK and HMC, which while trading cheap at this moment, are generating robust growth rates on strong fundamentals.

    Masimo's (MASI) Telehealth Solution Helps in COVID-19 Crisis

    by Zacks Equity Research

    Masimo (MASI) is lending support to Renown Health through Masimo SafetyNet in order to manage the COVID-19 surge.

    Here's Why You Should Retain Allscripts (MDRX) Stock for Now

    by Zacks Equity Research

    Investor confidence is high on Allscripts (MDRX) stock on the back of its solid prospects.

      Here's Why You Should Retain AmerisourceBergen (ABC) Now

      by Zacks Equity Research

      AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches.

      Abiomed's (ABMD) ECMO Technology Completes Successful Treatment

      by Zacks Equity Research

      Abiomed (ABMD) successfully treats first two patients in the world with the help of its Breethe OXY-1 System.

      Here's Why You Should Retain Stryker Stock Right Now

      by Zacks Equity Research

      Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises concern.

      NextGen (NXGN) Solutions Support COVID-19 Vaccine Distribution

      by Zacks Equity Research

      NextGen (NXGN) lends a hand to the nationwide rollout of COVID-19 vaccines through its robust EHR platform and integrated solutions.

      Should Value Investors Buy McKesson (MCK) Stock?

      by Zacks Equity Research

      Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

      MCK vs. WST: Which Stock Is the Better Value Option?

      by Zacks Equity Research

      MCK vs. WST: Which Stock Is the Better Value Option?